Home » Healthcare » Mexico Cartilage Repair Regeneration Market

Mexico Cartilage Repair Regeneration Market By Type of Cartilage (Fibrocartilage, Hyaline Cartilage, Others); By Treatment Modalities (Cell-Based Approaches, Non-Cell-Based Approaches); By Treatment Type (Palliative, Intrinsic Repair Stimulus); By Application (Knee, Spine, Ankle, Hip, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Mexico Cartilage Repair Regeneration Market Size 2024	USD 179.06 million
Mexico Cartilage Repair Regeneration Market, CAGR	4.04%
Mexico Cartilage Repair Regeneration Market Size 2032	USD 245.87 million

Market Overview

The Mexico Cartilage Repair Regeneration Market is projected to grow from USD 179.06 million in 2024 to an estimated USD 245.87 million by 2032, with a compound annual growth rate (CAGR) of 4.04% from 2025 to 2032. This growth is driven by advancements in regenerative medicine and increased healthcare investments in the country, particularly for musculoskeletal diseases and joint repair treatments.

Several factors contribute to the expansion of the cartilage repair regeneration market in Mexico. Increasing awareness of regenerative therapies, such as stem cell treatments and tissue engineering, is propelling market growth. Additionally, the growing geriatric population, which is more susceptible to cartilage degeneration, is a key driver for the market. Technological innovations in cartilage repair methods, such as autologous chondrocyte implantation (ACI) and matrix-induced autologous chondrocyte implantation (MACI), are enhancing the efficacy of treatments and further stimulating market demand. Furthermore, rising healthcare expenditure and better access to advanced therapies are driving the market’s positive outlook.

Geographically, Mexico’s cartilage repair market is witnessing significant growth, particularly in urban centers with well-established healthcare infrastructure. Key players in this market include Medtronic, Zimmer Biomet, Stryker Corporation, and Smith & Nephew, which are actively expanding their product offerings to cater to the increasing demand for cartilage repair treatments. These companies focus on the development of advanced therapies and strategic collaborations to enhance their market presence in Mexico and beyond.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Mexico Cartilage Repair Regeneration Market is projected to grow from USD 179.06 million in 2024 to USD 245.87 million by 2032, with a CAGR of 4.04%.
The Global Cartilage Repair Regeneration Market reached USD 5,599.25 million in 2024 and will grow at a 5.58 % CAGR to USD 8,648.13 million by 2032.
Advancements in regenerative medicine, rising healthcare investments, and the increasing prevalence of cartilage-related conditions are driving market growth.
Cell-based therapies and tissue engineering are enhancing the effectiveness of cartilage repair treatments, propelling the market forward.
The growing aging population in Mexico is a significant driver, as older adults are more prone to cartilage degeneration and joint diseases.
Urban centers with well-established healthcare systems are seeing higher demand for advanced cartilage repair treatments.
High treatment costs and limited access in rural areas could hinder broader market adoption, especially in underserved regions.
While urban areas lead the market, rural regions present significant growth opportunities with increased access to regenerative therapies.

Report Scope

This report segments the Mexico Cartilage Repair Regeneration Market as follows:

Market Drivers

Increasing Prevalence of Osteoarthritis and Joint Disorders

The rising prevalence of osteoarthritis and other joint-related disorders is a significant driver for the Mexico Cartilage Repair Regeneration Market. As the population ages, the incidence of degenerative cartilage diseases increases, particularly in older individuals. This growing health concern has raised demand for effective treatments that restore cartilage function and improve quality of life. The need for more advanced and minimally invasive repair methods is increasing, driving the adoption of cartilage regeneration technologies.

For instance, Mexico recorded over 38,400 cartilage-related disorder cases in 2022, highlighting the increasing demand for effective repair therapies.

Technological Advancements in Cartilage Repair

Technological advancements in cartilage repair techniques are rapidly shaping the Mexico Cartilage Repair Regeneration Market. Innovations such as stem cell therapies, tissue engineering, and autologous chondrocyte implantation (ACI) have greatly improved the effectiveness of treatments. These breakthroughs offer patients better outcomes with fewer complications and faster recovery times. The continuous development of new materials, scaffolds, and biologics in cartilage regeneration is pushing the market forward, providing greater options for healthcare providers and patients alike.

For instance, Mexico has seen a significant rise in the adoption of advanced cartilage repair techniques, with leading companies such as Zimmer Biomet and Stryker driving innovation in the field.

Rising Healthcare Awareness and Demand for Minimally Invasive Treatments

There is an increasing awareness of cartilage repair treatments among both patients and healthcare providers in Mexico. As people become more educated about the potential benefits of regenerative medicine, they are seeking out advanced therapies for cartilage repair. This awareness is driving demand for minimally invasive treatment options that require shorter recovery times and offer more natural healing processes. The preference for these less invasive methods contributes to the expansion of the Mexico Cartilage Repair Regeneration Market.

Government Initiatives and Healthcare Investment

Government initiatives and increased investment in the healthcare sector are contributing to the growth of the Mexico Cartilage Repair Regeneration Market. Mexico’s healthcare infrastructure has seen improvements in recent years, with more funding directed towards modernizing medical services and expanding access to advanced treatments. These investments create a favorable environment for the adoption of regenerative therapies, benefiting both medical professionals and patients in the region.

Market Trends

Growing Adoption of Regenerative Medicine Technologies

The Mexico Cartilage Repair Regeneration Market is experiencing a significant shift toward the adoption of regenerative medicine technologies. Stem cell therapy, tissue engineering, and other advanced biologic treatments are gaining traction due to their ability to promote natural healing and restore damaged cartilage. These therapies are becoming increasingly popular for patients seeking long-term, effective solutions to cartilage degeneration. As healthcare providers gain a better understanding of the potential benefits, they are incorporating these technologies into their treatment offerings. This trend reflects a broader movement toward regenerative medicine across the global healthcare landscape, influencing the Mexican market.

For instance, in 2024, more than 6,500 regenerative medicine procedures for cartilage repair were performed in Mexico, highlighting the increasing adoption of advanced biologic treatments

Shift Toward Minimally Invasive Procedures

Minimally invasive procedures are becoming a key trend in the Mexico Cartilage Repair Regeneration Market, with patients and healthcare professionals alike preferring options that offer quicker recovery times and reduced surgical risks. Technologies such as autologous chondrocyte implantation (ACI) and matrix-induced autologous chondrocyte implantation (MACI) are gaining popularity due to their ability to regenerate cartilage without the need for large incisions or long recovery periods. These procedures align with growing patient demand for efficient, cost-effective, and minimally disruptive treatments. As the market for cartilage repair evolves, the shift towards less invasive techniques continues to shape the landscape, providing more options for treating cartilage damage.

For instance, as of 2025, over 3,200 patients in Mexico have undergone minimally invasive cartilage repair procedures, demonstrating the rising preference for less invasive treatment options

Market Challenges

High Treatment Costs and Limited Access

One of the primary challenges faced by the Mexico Cartilage Repair Regeneration Market is the high cost of advanced treatment options. Regenerative therapies such as stem cell treatments and tissue engineering require significant investment in research and development, which can make these treatments expensive for both patients and healthcare providers. This cost barrier limits access to these therapies, particularly for patients in lower-income brackets or in rural regions with less developed healthcare infrastructure. While urban centers see increasing adoption, underserved areas are still struggling to access advanced cartilage repair solutions.

For instance, the cost of stem cell therapy for cartilage repair in Mexico ranges between 39,000 and 72,000, making it financially challenging for many patients to afford advanced treatment options

Regulatory and Market Barriers

The regulatory environment in Mexico presents another challenge for the Cartilage Repair Regeneration Market. Stringent approval processes for new medical treatments, along with the need for continuous regulatory compliance, can delay the introduction of innovative therapies. These hurdles create barriers for market players trying to bring new and effective treatments to the market quickly. Despite ongoing improvements in the healthcare sector, the market faces challenges in meeting the rising demand for cartilage repair treatments without overcoming these regulatory delays and market entry obstacles.

Market Opportunities

Expanding Access to Advanced Healthcare Treatments

The Mexico Cartilage Repair Regeneration Market presents significant opportunities through expanding access to advanced healthcare treatments. With improving healthcare infrastructure and rising medical awareness, there is an increasing opportunity to provide innovative cartilage repair solutions in underserved regions. The growing middle-class population in Mexico is driving demand for high-quality, affordable treatments. Healthcare providers have the chance to expand their offerings of regenerative therapies, particularly in rural areas where access to specialized care may be limited.

Collaborations and Strategic Partnerships for Growth

Strategic collaborations between local healthcare providers and global players in the regenerative medicine sector offer substantial growth opportunities for the Mexico Cartilage Repair Regeneration Market. Partnerships can enhance product distribution and ensure the availability of advanced therapies to a broader patient base. Joint ventures could also accelerate research and development efforts, leading to new treatment options and better patient outcomes. The market offers ample space for expansion as multinational companies seek to tap into the growing demand for cartilage repair treatments in Mexico.

Market Segmentation Analysis

By Type of Cartilage

The Mexico Cartilage Repair Regeneration Market is segmented based on the type of cartilage, including fibrocartilage, hyaline cartilage, and others. Hyaline cartilage is the most prevalent in cartilage repair treatments, often targeted due to its role in joint function. Fibrocartilage is less frequently treated but plays a crucial role in repairing damaged cartilage through its unique properties. Treatments for these different types vary in complexity and effectiveness, catering to specific cartilage repair needs across different patients.

By Treatment Modalities

The market is further divided into cell-based and non-cell-based approaches. Cell-based approaches are gaining momentum due to their ability to regenerate cartilage by introducing cells that encourage tissue repair. These therapies include stem cell treatments and chondrocyte transplantation. Non-cell-based approaches, while effective, typically focus on scaffolds or biologic implants that support cartilage regeneration without introducing new cells. Both treatment modalities are essential, with cell-based approaches showing more advanced outcomes in severe cartilage damage cases.

Segments

Based on Type of Cartilage

Fibrocartilage
Hyaline Cartilage
Others

Based on Treatment Modalities

Cell-Based Approaches
Non-Cell-Based Approaches

Based on Treatment Type

Palliative
Intrinsic Repair Stimulus

Based on Application

Knee
Spine
Ankle
Hip
Others

Based on Region

Mexico City
Guadalajara
Monterrey

Regional Analysis

Market Overview and Growth in Urban Areas

The Mexico Cartilage Repair Regeneration Market shows considerable potential, particularly in urban regions with well-developed healthcare infrastructure. Major cities such as Mexico City, Guadalajara, and Monterrey serve as key hubs for advanced medical treatments, offering access to specialized healthcare providers and cutting-edge cartilage repair technologies. These urban areas are experiencing higher demand for cartilage repair treatments due to a growing middle class and an increase in age-related degenerative diseases such as osteoarthritis. The availability of state-of-the-art medical facilities in these regions contributes to the rapid adoption of both cell-based and non-cell-based treatment approaches.

Opportunities for Expansion in Rural Regions

While urban areas lead in market demand, there are significant opportunities for expansion in rural and underserved regions of Mexico. Limited access to specialized care in these areas has resulted in a gap in the availability of advanced cartilage repair treatments. With Mexico’s expanding healthcare initiatives and increasing governmental investments, there is potential to address these disparities by bringing regenerative medicine technologies to rural clinics and hospitals. This expansion could open up the market to a wider patient population, boosting the adoption of cartilage repair solutions across the country.

Competitive Landscape and Key Players

The Mexico Cartilage Repair Regeneration Market is highly competitive, with both local and international players offering a wide range of treatment options. Key multinational companies such as Zimmer Biomet, Medtronic, and Stryker Corporation dominate the market, contributing significantly to its growth through strategic partnerships, product innovations, and distribution networks. These companies are increasingly focused on expanding their market reach by collaborating with local healthcare providers to improve patient access to advanced treatments. As competition intensifies, further innovation in both treatment modalities and technologies is expected to drive market development.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Biomateriales S.A. de C.V.
Meditec S.A. de C.V.
Ortopedia y Traumatología S.A. de C.V.
Ortopedia Integral S.A. de C.V.
Soluciones Ortopédicas S.A. de C.V.

Competitive Analysis

The Mexico Cartilage Repair Regeneration Market is highly competitive, with several established players focusing on expanding their market presence. Companies like Biomateriales S.A. de C.V., Meditec S.A. de C.V., and Ortopedia y Traumatología S.A. de C.V. dominate the landscape by offering a diverse range of cartilage repair products and services. These players continuously invest in research and development to introduce innovative treatment solutions, such as cell-based and non-cell-based therapies. Ortopedia Integral S.A. de C.V. and Soluciones Ortopédicas S.A. de C.V. are strengthening their foothold by enhancing their product portfolios and improving customer access to regenerative therapies. The market’s competitive nature drives these companies to focus on product differentiation, customer service, and strategic partnerships to improve market share.

Recent Developments

In April 2024, Zimmer Biomet and Arthrogenics entered a partnership to co-develop next-generation biologic medicines for cartilage repair, aiming to leverage Arthrogenics’ cell-therapy expertise alongside Zimmer Biomet’s orthopedic portfolio.

In February 2024, the U.S. FDA granted 510(k) clearance for Zimmer Biomet’s ROSA Shoulder System, the first robotic-assisted solution cleared for total and reverse shoulder arthroplasty, signaling enhanced precision in joint restoration procedures.

In June 2024, Askel Healthcare Ltd presented first clinical-trial results of its COPLA knee cartilage implant at the 9th Joint Preservation Congress in Warsaw, demonstrating early safety and functional gains in focal cartilage repair.

On September 17, 2024, Sparta Biomedical announced treatment of the first patients with its Ormi™ partial-knee resurfacing device, a biomimetic implant designed to restore cartilage function and slow osteoarthritis progression.

On December 18, 2024, Mesoblast’s Ryoncil (remestemcel-L) received U.S. FDA approval as the first mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, paving the way for broader MSC applications—including potential off-label exploration in cartilage repair contexts.

On May 8, 2025, Smith + Nephew published 4-year follow-up data showing that patients treated with its CARTIHEAL™ AGILI-C™ implant experienced an 87% lower risk of eventual knee arthroplasty or osteotomy, underscoring long-term implant durability and functional improvement.

In February 2025, Mesoblast reported financial and operational results confirming advancement of its proprietary mesenchymal-cell platform; the report noted ongoing preparation for pivotal trials in orthopedic indications, including chronic low back pain and osteoarthritis models.

Market Concentration and Characteristics

The Mexico Cartilage Repair Regeneration Market is moderately concentrated, with a few key players dominating the landscape. The market is characterized by a mix of multinational companies and local players offering a range of advanced cartilage repair treatments. Large multinational firms hold a significant market share due to their established brand presence and extensive product portfolios. Local players, however, are gaining ground by catering to the specific needs of the Mexican population with tailored solutions and more affordable treatment options. The market’s characteristics include rapid technological advancements, increasing healthcare investment, and a growing preference for minimally invasive procedures. Competitive dynamics are driven by product innovation, pricing strategies, and the expanding demand for regenerative medicine in orthopedic care. Companies are focused on improving patient outcomes through continuous development of advanced therapies.

Report Coverage

The research report offers an in-depth analysis based on Type of Cartilage, Treatment Modalities, Treatment Type, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The market is expected to see an increase in the variety of available treatments, with advancements in cell-based and non-cell-based therapies offering more choices to patients with cartilage damage.

As regenerative medicine continues to evolve, its adoption in cartilage repair will expand, providing patients with innovative, minimally invasive solutions to restore cartilage function.

With Mexico’s aging population growing, the demand for cartilage repair treatments, particularly for osteoarthritis and other degenerative joint diseases, will increase.

Ongoing improvements in Mexico’s healthcare system will provide increased access to advanced treatments, driving market growth by making cartilage repair therapies more widely available.

Continuous innovations in tissue engineering and stem cell therapies will enhance the effectiveness of cartilage repair, enabling better outcomes for patients and expanding treatment options.

There will be a growing preference for minimally invasive procedures, such as autologous chondrocyte implantation, due to their shorter recovery times and lower risk profiles.

The market will witness intensified competition, with both global and local players striving to expand their market share through strategic partnerships, product innovations, and improved service offerings

The trend toward personalized medicine will drive the development of tailored cartilage repair solutions, catering to the specific needs of individual patients for better results.

Key players will focus on expanding their reach beyond urban areas to cater to underserved regions, improving patient access to cartilage repair treatments in rural Mexico.

Rising awareness about regenerative therapies and their benefits will lead to increased demand for advanced cartilage repair treatments, shaping the future of the Mexico Cartilage Repair Regeneration Market.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Type of Cartilages 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Mexico Cartilage Repair Regeneration Market Snapshot 21

2.1.1. Mexico Cartilage Repair Regeneration Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – INDUSTRY ANALYSIS 23

3.1. Introduction 23

3.2. Market Drivers 24

3.2.1. Availability of Cost-Effective Treatment Options 24

3.2.2. Government Initiatives to Promote Medical Tourism 25

3.3. Market Restraints 26

3.3.1. Shortage of Skilled Medical Professionals 26

3.4. Market Opportunities 27

3.4.1. Market Opportunity Analysis 27

3.5. Porter’s Five Forces Analysis 28

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29

4.1. Company Market Share Analysis – 2024 29

4.1.1. Mexico Cartilage Repair Regeneration Market: Company Market Share, by Revenue, 2024 29

4.1.2. Mexico Cartilage Repair Regeneration Market: Top 6 Company Market Share, by Revenue, 2024 29

4.1.3. Mexico Cartilage Repair Regeneration Market: Top 3 Company Market Share, by Revenue, 2024 30

4.2. Mexico Cartilage Repair Regeneration Market Company Revenue Market Share, 2024 31

4.3. Company Assessment Metrics, 2024 32

4.3.1. Stars 32

4.3.2. Emerging Leaders 32

4.3.3. Pervasive Players 32

4.3.4. Participants 32

4.4. Start-ups /SMEs Assessment Metrics, 2024 32

4.4.1. Progressive Companies 32

4.4.2. Responsive Companies 32

4.4.3. Dynamic Companies 32

4.4.4. Starting Blocks 32

4.5. Strategic Developments 33

4.5.1. Acquisitions & Mergers 33

New Product Launch 33

Mexico Expansion 33

4.6. Key Players Product Matrix 34

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 35

5.1. PESTEL 35

5.1.1. Political Factors 35

5.1.2. Economic Factors 35

5.1.3. Social Factors 35

5.1.4. Technological Factors 35

5.1.5. Environmental Factors 35

5.1.6. Legal Factors 35

5.2. Adjacent Market Analysis 35

CHAPTER NO. 6 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – BY TYPE OF CARTILAGE SEGMENT ANALYSIS 36

6.1. Mexico Cartilage Repair Regeneration Market Overview, by Type of Cartilage Segment 36

6.1.1. Mexico Cartilage Repair Regeneration Market Revenue Share, By Type of Cartilage, 2023 & 2032 37

6.1.2. Mexico Cartilage Repair Regeneration Market Attractiveness Analysis, By Type of Cartilage 38

6.1.3. Incremental Revenue Growth Opportunity, by Type of Cartilage, 2024 – 2032 38

6.1.4. Mexico Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018, 2023, 2027 & 2032 39

6.2. Fibrocartilage 40

6.3. Hyaline Cartilage 41

6.4. Others 42

CHAPTER NO. 7 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – BY TREATMENT MODALITIES SEGMENT ANALYSIS 43

7.1. Mexico Cartilage Repair Regeneration Market Overview, by Treatment Modalities Segment 43

7.1.1. Mexico Cartilage Repair Regeneration Market Revenue Share, By Treatment Modalities, 2023 & 2032 44

7.1.2. Mexico Cartilage Repair Regeneration Market Attractiveness Analysis, By Treatment Modalities 45

7.1.3. Incremental Revenue Growth Opportunity, by Treatment Modalities, 2024 – 2032 45

7.1.4. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018, 2023, 2027 & 2032 46

7.2. Cell-Based Approaches 47

7.3. Non-Cell-Based Approaches 48

CHAPTER NO. 8 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 49

8.1. Mexico Cartilage Repair Regeneration Market Overview, by Treatment Type Segment 49

8.1.1. Mexico Cartilage Repair Regeneration Market Revenue Share, By Treatment Type, 2023 & 2032 50

8.1.2. Mexico Cartilage Repair Regeneration Market Attractiveness Analysis, By Treatment Type 51

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 51

8.1.4. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 52

8.2. Palliative 53

8.3. Intrinsic Repair Stimulus 54

CHAPTER NO. 9 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – BY APPLICATION SEGMENT ANALYSIS 55

9.1. Mexico Cartilage Repair Regeneration Market Overview, by Application Segment 55

9.1.1. Mexico Cartilage Repair Regeneration Market Revenue Share, By Application, 2023 & 2032 56

9.1.2. Mexico Cartilage Repair Regeneration Market Attractiveness Analysis, By Application 57

9.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 57

9.1.4. Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2018, 2023, 2027 & 2032 58

9.2. Knee 59

9.3. Spine 60

9.4. Ankle 61

9.5. Hip 62

9.6. Others 63

CHAPTER NO. 10 : MEXICO CARTILAGE REPAIR REGENERATION MARKET – ANALYSIS 64

10.1. Type of Cartilage 64

10.1.1. Mexico Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018 – 2023 (USD Million) 64

10.1.2. Mexico Cartilage Repair Regeneration Market Revenue, By Type, 2024 – 2032 (USD Million) 64

10.2. Treatment Modalities 65

10.2.1. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018 – 2023 (USD Million) 65

10.2.2. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2024 – 2032 (USD Million) 65

10.3. Treatment Type 66

10.3.1. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 66

10.3.2. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 66

10.4. Application 67

10.4.1. Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2018 – 2023 (USD Million) 67

10.4.2. Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2024 – 2032 (USD Million) 67

CHAPTER NO. 11 : COMPANY PROFILES 68

11.1. Biomateriales S.A. de C.V. 68

11.1.1. Company Overview 68

11.1.2. Product Portfolio 68

11.1.3. Swot Analysis 68

11.1.4. Business Strategy 69

11.1.5. Financial Overview 69

11.2. Meditec S.A. de C.V. 70

11.3. Ortopedia y Traumatología S.A. de C.V. 70

11.4. Ortopedia Integral S.A. de C.V. 70

11.5. Soluciones Ortopédicas S.A. de C.V. 70

11.6. Company 6 70

11.7. Company 7 70

11.8. Company 8 70

11.9. Company 9 70

11.10. Company 10 70

List of Figures

FIG NO. 1. Mexico Cartilage Repair Regeneration Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Mexico Cartilage Repair Regeneration Market 28

FIG NO. 3. Company Share Analysis, 2024 29

FIG NO. 4. Company Share Analysis, 2024 29

FIG NO. 5. Company Share Analysis, 2024 30

FIG NO. 6. Mexico Cartilage Repair Regeneration Market – Company Revenue Market Share, 2024 31

FIG NO. 7. Mexico Cartilage Repair Regeneration Market Revenue Share, By Type of Cartilage, 2023 & 2032 37

FIG NO. 8. Market Attractiveness Analysis, By Type of Cartilage 38

FIG NO. 9. Incremental Revenue Growth Opportunity by Type of Cartilage, 2024 – 2032 38

FIG NO. 10. Mexico Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018, 2023, 2027 & 2032 39

FIG NO. 11. Mexico Cartilage Repair Regeneration Market for Fibrocartilage, Revenue (USD Million) 2018 – 2032 40

FIG NO. 12. Mexico Cartilage Repair Regeneration Market for Hyaline Cartilage, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. Mexico Cartilage Repair Regeneration Market for Others, Revenue (USD Million) 2018 – 2032 42

FIG NO. 14. Mexico Cartilage Repair Regeneration Market Revenue Share, By Treatment Modalities, 2023 & 2032 44

FIG NO. 15. Market Attractiveness Analysis, By Treatment Modalities 45

FIG NO. 16. Incremental Revenue Growth Opportunity by Treatment Modalities, 2024 – 2032 45

FIG NO. 17. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018, 2023, 2027 & 2032 46

FIG NO. 18. Mexico Cartilage Repair Regeneration Market for Cell-Based Approaches, Revenue (USD Million) 2018 – 2032 47

FIG NO. 19. Mexico Cartilage Repair Regeneration Market for Non-Cell-Based Approaches, Revenue (USD Million) 2018 – 2032 48

FIG NO. 20. Mexico Cartilage Repair Regeneration Market Revenue Share, By Treatment Type, 2023 & 2032 50

FIG NO. 21. Market Attractiveness Analysis, By Treatment Type 51

FIG NO. 22. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 51

FIG NO. 23. Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 52

FIG NO. 24. Mexico Cartilage Repair Regeneration Market for Palliative, Revenue (USD Million) 2018 – 2032 53

FIG NO. 25. Mexico Cartilage Repair Regeneration Market for Intrinsic Repair Stimulus, Revenue (USD Million) 2018 – 2032 54

FIG NO. 26. Mexico Cartilage Repair Regeneration Market Revenue Share, By Application, 2023 & 2032 56

FIG NO. 27. Market Attractiveness Analysis, By Application 57

FIG NO. 28. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 57

FIG NO. 29. Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2018, 2023, 2027 & 2032 58

FIG NO. 30. Mexico Cartilage Repair Regeneration Market for Knee, Revenue (USD Million) 2018 – 2032 59

FIG NO. 31. Mexico Cartilage Repair Regeneration Market for Spine, Revenue (USD Million) 2018 – 2032 60

FIG NO. 32. Mexico Cartilage Repair Regeneration Market for Ankle, Revenue (USD Million) 2018 – 2032 61

FIG NO. 33. Mexico Cartilage Repair Regeneration Market for Hip, Revenue (USD Million) 2018 – 2032 62

FIG NO. 34. Mexico Cartilage Repair Regeneration Market for Others, Revenue (USD Million) 2018 – 2032 63

List of Tables

TABLE NO. 1. : Mexico Cartilage Repair Regeneration Market: Snapshot 21

TABLE NO. 2. : Drivers for the Mexico Cartilage Repair Regeneration Market: Impact Analysis 24

TABLE NO. 3. : Restraints for the Mexico Cartilage Repair Regeneration Market: Impact Analysis 26

TABLE NO. 4. : Mexico Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2018 – 2023 (USD Million) 64

TABLE NO. 5. : Mexico Cartilage Repair Regeneration Market Revenue, By Type of Cartilage, 2024 – 2032 (USD Million) 64

TABLE NO. 6. : Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Modalities, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : Mexico Cartilage Repair Regeneration Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 66

TABLE NO. 10. : Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2018 – 2023 (USD Million) 67

TABLE NO. 11. : Mexico Cartilage Repair Regeneration Market Revenue, By Application, 2024 – 2032 (USD Million) 67

Frequently Asked Questions

What is the market size of the Mexico Cartilage Repair Regeneration Market in 2023 and 2032?

The market size of the Mexico Cartilage Repair Regeneration Market is projected to be USD 179.06 million in 2024 and is expected to reach USD 245.87 million by 2032.

What is the expected CAGR of the Mexico Cartilage Repair Regeneration Market?

The market is projected to grow at a compound annual growth rate (CAGR) of 4.04% from 2025 to 2032.

What are the key drivers of growth in the Mexico Cartilage Repair Regeneration Market?

Key drivers include advancements in regenerative medicine, rising healthcare investments, the growing geriatric population, and increasing prevalence of cartilage-related conditions.

Who are the key players in the Mexico Cartilage Repair Regeneration Market?

Key players include Medtronic, Zimmer Biomet, Stryker Corporation, and Smith & Nephew, which are expanding their product offerings to cater to the growing demand in Mexico.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –